Daunorubicin
(Redirected from Cerubidin)
An anthracycline antibiotic used in cancer treatment
Engineered Monoclonal Antibodies[edit source]
Engineered monoclonal antibodies are a class of biological therapies that are designed to target specific antigens on the surface of cells. These antibodies are produced using recombinant DNA technologies and are used in the treatment of various diseases, including cancer, autoimmune disorders, and infectious diseases.
Structure and Function[edit source]
Monoclonal antibodies are composed of two identical heavy chains and two identical light chains, forming a Y-shaped molecule. The tips of the "Y" contain the antigen-binding sites, which are highly specific to the target antigen. This specificity allows monoclonal antibodies to bind to their target with high affinity, blocking or modulating the function of the antigen.
Types of Engineered Monoclonal Antibodies[edit source]
There are several types of engineered monoclonal antibodies, each designed for specific therapeutic purposes:
- Chimeric antibodies: These antibodies are composed of murine (mouse) variable regions and human constant regions. They are less immunogenic than fully murine antibodies.
- Humanized antibodies: These antibodies are mostly human, with only the antigen-binding sites derived from murine sources. This reduces the risk of immune reactions.
- Fully human antibodies: These are entirely human in origin, produced using transgenic mice or phage display technologies.
- Bispecific antibodies: These antibodies are engineered to bind two different antigens simultaneously, offering unique therapeutic mechanisms.
Applications in Medicine[edit source]
Engineered monoclonal antibodies have revolutionized the treatment of many diseases:
- Cancer therapy: Monoclonal antibodies can target specific tumor antigens, leading to direct tumor cell killing or recruitment of immune cells to attack the tumor.
- Autoimmune diseases: By targeting specific components of the immune system, monoclonal antibodies can reduce inflammation and tissue damage in diseases such as rheumatoid arthritis and multiple sclerosis.
- Infectious diseases: Monoclonal antibodies can neutralize pathogens or their toxins, providing passive immunity or enhancing the host's immune response.
Production[edit source]
The production of engineered monoclonal antibodies involves several steps:
1. Antigen identification: The target antigen is identified and characterized. 2. Hybridoma technology: B cells from immunized animals are fused with myeloma cells to create hybridomas that produce the desired antibody. 3. Recombinant DNA technology: Genes encoding the antibody are cloned and expressed in suitable host cells, such as Chinese hamster ovary cells. 4. Purification and formulation: The antibodies are purified and formulated for clinical use.
Challenges and Future Directions[edit source]
While engineered monoclonal antibodies have shown great promise, there are challenges such as high production costs, potential for immune reactions, and the development of resistance. Ongoing research aims to improve antibody design, reduce immunogenicity, and enhance therapeutic efficacy.
Related Pages[edit source]
Daunorubicin, also known as daunomycin, is an anthracycline antibiotic that is primarily used in the treatment of certain types of cancer, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is a chemotherapy agent that works by intercalating DNA, thereby inhibiting the synthesis of nucleic acids and inducing apoptosis in rapidly dividing cells.
Mechanism of Action[edit | edit source]
Daunorubicin exerts its effects by intercalating between base pairs in the DNA helix, thereby disrupting the function of topoisomerase II, an enzyme critical for DNA replication and repair. This interference prevents the proper unwinding of DNA, leading to breaks in the DNA strands and ultimately triggering cell death. Additionally, daunorubicin generates free radicals that cause further damage to cellular components.
Clinical Uses[edit | edit source]
Daunorubicin is primarily used in the treatment of:
- Acute myeloid leukemia (AML)
- Acute lymphoblastic leukemia (ALL)
It is often used in combination with other chemotherapeutic agents, such as cytarabine, to enhance its efficacy. The drug is administered intravenously, allowing it to rapidly reach systemic circulation and target cancerous cells throughout the body.
Side Effects[edit | edit source]
The use of daunorubicin is associated with several side effects, which can vary in severity. Common side effects include:
- Myelosuppression, leading to decreased production of blood cells
- Nausea and vomiting
- Alopecia (hair loss)
- Cardiotoxicity, which can lead to congestive heart failure
Due to its potential to cause cardiotoxicity, the cumulative dose of daunorubicin is carefully monitored, and patients may undergo regular cardiac evaluations during treatment.
Pharmacokinetics[edit | edit source]
Daunorubicin is metabolized primarily in the liver and is excreted in the bile and urine. Its half-life is approximately 18.5 hours, allowing for effective dosing schedules in chemotherapy regimens. The drug's lipophilic nature facilitates its penetration into tissues, including the central nervous system, although its efficacy in treating central nervous system leukemia is limited.
History[edit | edit source]
Daunorubicin was first isolated from the bacterium Streptomyces peucetius in the 1960s. It was one of the first anthracyclines to be used in clinical practice and paved the way for the development of other related compounds, such as doxorubicin.
Related pages[edit | edit source]
Daunorubicin[edit | edit source]
Daunorubicin[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD